We are live on ! Find out more
LAB icon

Standard BioTools
LAB

109 hedge funds and large institutions have $252M invested in Standard BioTools in 2015 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 36 increasing their positions, 35 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more call options, than puts

Call options by funds: $12.8M | Put options by funds: $7.69M

14% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 22

2% more funds holding

Funds holding: 107 → 109 (+2)

3% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 35

66% less capital invested

Capital invested by funds: $750M → $252M (-$498M)

Holders
109
Holders Change
+2
Holders Change %
+1.87%
% of All Funds
3.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
36
Reduced
35
Closed
22
Calls
$12.8M
Puts
$7.69M
Net Calls
+$5.15M
Net Calls Change
+$4.4M

Top Buyers

1
SCM
Scopia Capital Management
New York
+$20.6M
2
Capital World Investors
Capital World Investors
California
+$12.6M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$9.97M
4
Citadel Advisors
Citadel Advisors
Florida
+$8.87M
5
Goldman Sachs
Goldman Sachs
New York
+$7.33M

Top Sellers

1
Jennison Associates
Jennison Associates
New York
-$27.6M
2
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$16.7M
3
JP Morgan Chase
JP Morgan Chase
New York
-$14.8M
4
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM)
Texas
-$12.9M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$12.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Primecap Management
1
Primecap Management
California
$34.6M +$3.11M +197,300 +5%
Franklin Resources
2
Franklin Resources
California
$23M +$2.96M +187,748 +7%
O
3
OrbiMed
New York
$19.9M – – –
WA
4
Wasatch Advisors
Utah
$19.8M -$1.05M -66,820 -3%
JP Morgan Chase
5
JP Morgan Chase
New York
$16.2M -$14.8M -942,728 -32%
SCM
6
Scopia Capital Management
New York
$10.6M +$20.6M +1,307,790 New
Jennison Associates
7
Jennison Associates
New York
$8.82M -$27.6M -1,753,598 -62%
Vanguard Group
8
Vanguard Group
Pennsylvania
$8.09M +$329K +20,931 +2%
EAM
9
EverPoint Asset Management
Connecticut
$7.3M +$4.72M +300,000 +50%
BFA
10
BlackRock Fund Advisors
California
$6.81M -$538K -34,174 -4%
Capital World Investors
11
Capital World Investors
California
$6.49M +$12.6M +800,000 New
BIT
12
BlackRock Institutional Trust
California
$5.95M +$2.06M +130,782 +22%
Schroder Investment Management Group
13
Schroder Investment Management Group
United Kingdom
$5.92M -$3.24M -206,000 -22%
Wellington Management Group
14
Wellington Management Group
Massachusetts
$5.14M +$9.97M +633,468 New
Millennium Management
15
Millennium Management
New York
$5.13M +$4.11M +261,361 +70%
SM
16
Sabby Management
Florida
$5.09M +$7.29M +462,875 +280%
Citadel Advisors
17
Citadel Advisors
Florida
$5.08M +$8.87M +563,707 +892%
Lazard Asset Management
18
Lazard Asset Management
New York
$4.38M +$1.77M +112,246 +26%
ECM
19
Endurant Capital Management
California
$4.04M +$7.23M +459,568 +1,203%
Goldman Sachs
20
Goldman Sachs
New York
$3.78M +$7.33M +465,987 New
State Street
21
State Street
Massachusetts
$3.57M -$136K -8,620 -2%
Neuberger Berman Group
22
Neuberger Berman Group
New York
$3.36M +$6.53M +414,559 New
HCMT
23
Highland Capital Management (Texas)
Texas
$3.31M +$117K +7,432 +2%
Northern Trust
24
Northern Trust
Illinois
$2.87M -$9.93K -631 -0.2%
Deutsche Bank
25
Deutsche Bank
Germany
$2.85M +$1.55M +98,401 +39%
1
2 3 4 5

LAB Hedge Fund Activity: Q3 2015 in Review

109 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q3 2015, worth a combined $252M — down 66% from $750M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new LAB positions and 22 closed out — a net gain of 3 holders — while 36 added to existing stakes and 35 trimmed.

The largest buyer was Scopia Capital Management, opening a new position worth an estimated $20.6M. The largest seller was Jennison Associates, cutting an estimated $27.6M.

  • 109 institutional investors held Standard BioTools (LAB) as of Q3 2015, up from 107 in Q2 2015.
  • Funds reported $252M of Standard BioTools stock for Q3 2015, down 66% quarter-over-quarter.
  • 25 funds opened new Standard BioTools positions in Q3 2015 and 22 closed out, a net change of +3 holders.
  • The largest Standard BioTools buyer in Q3 2015 was Scopia Capital Management, an estimated $20.6M added.
  • The largest Standard BioTools seller in Q3 2015 was Jennison Associates, an estimated $27.6M sold.

Based on aggregated 13F filings for Q3 2015.